Syngenta Scientist: Eureka! Atrazine Doesn’t Cause Cancer

An herbicide applicator in action. Photo courtesy of Syngenta

Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.


As I reported a while back, sales of atrazine—a potent herbicide popular among large-scale corn farmers—are booming. That’s good news for atrazine-maker Syngenta, the globe’s largest pesticide company; and bad news for all ecosytems (including human ones) in and downstream from the places where farmers apply the nasty stuff.

The case against atrazine has gotten so strong that the EPA is actively considering joining the European Union in banning it. The EPA announced its review of atrazine in 2009 and suggested the process would take a year. In late July, the EPA committee overseeing the review met toi compare notes. An EPA press officer told me at the time it would be “upwards of 90 days” before the agency announced any decision.

Predictably enough, Syngenta is taking advantage of the slow-motion review to do what it did last time the EPA looked anew at the toxicology of atrazine, which was back in 2003: It’s funding research that exonerates its cash-cow herbicide and submitting it to the EPA. That tactic worked in ‘03, even though the Syngenta-bought research turned out to be pretty shoddy.

Pesticide Action Network’s Ground Truth blog points out that not long before the EPA’s July meeting, a team led by Syngenta employee Charles B. Breckenridge submitted a study claiming to show that atrazine isn’t linked to breast cancer, despite much evidence to the contrary. As the Physicians for Social Responsibility put it in a recent letter (PDF) to the EPA:

Several scientific studies have found a link between long-term exposure to atrazine and breast cancer. A study of women from all 120 counties of Kentucky showed a statistically significant increase in breast cancer risk with medium and high levels of atrazine exposure. A study from UK found a significant association between breast cancer rates and the application of atrazine in rural Leicestershire. Other studies using lab rats as subjects found exposure to atrazine increased risks of breast and prostrate cancers.

Surely, the EPA will heed the vast weight of independent research and train a skeptical eye on the company-funded stuff. Right? Pesticide Action Network isn’t sure. “Are we worried”? the group’s blog post asks. “Unfortunately, yes.”

HERE ARE THE FACTS:

Our fall fundraising drive is off to a rough start, and we very much need to raise $250,000 in the next couple of weeks. If you value the journalism you get from Mother Jones, please help us do it with a donation today.

As we wrote over the summer, traffic has been down at Mother Jones and a lot of sites with many people thinking news is less important now that Donald Trump is no longer president. But if you're reading this, you're not one of those people, and we're hoping we can rally support from folks like you who really get why our reporting matters right now. And that's how it's always worked: For 45 years now, a relatively small group of readers (compared to everyone we reach) who pitch in from time to time has allowed Mother Jones to do the type of journalism the moment demands and keep it free for everyone else.

Please pitch in with a donation during our fall fundraising drive if you can. We can't afford to come up short, and there's still a long way to go by November 5.

payment methods

ONE MORE QUICK THING:

Our fall fundraising drive is off to a rough start, and we very much need to raise $250,000 in the next couple of weeks. If you value the journalism you get from Mother Jones, please help us do it with a donation today.

As we wrote over the summer, traffic has been down at Mother Jones and a lot of sites with many people thinking news is less important now that Donald Trump is no longer president. But if you're reading this, you're not one of those people, and we're hoping we can rally support from folks like you who really get why our reporting matters right now. And that's how it's always worked: For 45 years now, a relatively small group of readers (compared to everyone we reach) who pitch in from time to time has allowed Mother Jones to do the type of journalism the moment demands and keep it free for everyone else.

Please pitch in with a donation during our fall fundraising drive if you can. We can't afford to come up short, and there's still a long way to go by November 5.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate